Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 35Myelodysplastic Syndromes 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Hematologic Neoplasms 14Leukemia, Myelogenous, Chronic, BCR-ABL Positive 13Lymphoma, Non-Hodgkin 12Myeloproliferative Disorders 11Lymphoma 11Leukemia, Myelomonocytic, Chronic 11Graft vs Host Disease 10Primary Myelofibrosis 9Leukemia 9Hodgkin Disease 9Leukemia, Lymphocytic, Chronic, B-Cell 7Anemia, Refractory, with Excess of Blasts 7Multiple Myeloma 6Leukemia, Biphenotypic, Acute 6Burkitt Lymphoma 5Polycythemia Vera 4Lymphoma, Follicular 4Leukemia, Myeloid 4Leukemia, Lymphoid 4Anemia, Aplastic 4Thrombocythemia, Essential 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precancerous Conditions 3Neoplasms, Plasma Cell 3Neoplasms 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoproliferative Disorders 3

Interventions

Bevacizumab 69atezolizumab 54lenvatinib 42durvalumab 42Nivolumab 38pembrolizumab 35tremelimumab 28Magnetic Resonance Spectroscopy 21Specimen Handling 19tislelizumab 18sintilimab 17Ipilimumab 15Sorafenib 14regorafenib 13cabozantinib 13Radiosurgery 13Radiotherapy 12apatinib 11Blood Specimen Collection 11Immunoglobulin G 10camrelizumab 9Immune Checkpoint Inhibitors 9Disulfides 9X-Rays 8Cyclophosphamide 8donafenib 7Oxaliplatin 7Immunotherapy 7Folfox protocol 7Fluorouracil 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Tacrolimus × 1 year × Clear all
NCT02081755 2026-01-27

Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer

Baylor Research Institute

Phase 4 Enrolling by invitation
336 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡